However, inappropriately reduced BCL11A expression could also result in a pathological sequence of chronic, relatively increased insulin secretion, leading to insulin resistance, beta cell exhaustion, and eventual hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.